Eton Pharmaceuticals, Inc. 宣布，除核心资产收购外，公司还计划在交易交割时购入价值约150万美元的库存产品。此外，根据安排，预计在2026年5月将再购入约70万美元的库存。这一举措旨在进一步充实公司的产品储备，支持其长期业务拓展。
Eton Pharmaceuticals, Inc. 宣布，除核心资产收购外，公司还计划在交易交割时购入价值约150万美元的库存产品。此外，根据安排，预计在2026年5月将再购入约70万美元的库存。这一举措旨在进一步充实公司的产品储备，支持其长期业务拓展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.